Family · Pharmaceutical analytical standards
Cangrelor
An intravenous antiplatelet drug that blocks the P2Y12 receptor, approved in 2015 to prevent clot formation during coronary angioplasty. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It is an ATP analogue: it acts within about two minutes and, because it is broken down directly in the blood, platelet function returns to normal about an hour after the infusion ends.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
